Caxton Associates LLP Evolus, Inc. Transaction History
Caxton Associates LLP
- $3.94 Trillion
- Q2 2025
A detailed history of Caxton Associates LLP transactions in Evolus, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 16,029 shares of EOLS stock, worth $104,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,029Holding current value
$104,188% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EOLS
# of Institutions
186Shares Held
55.6MCall Options Held
1.21MPut Options Held
48.5K-
Tang Capital Management LLC San Diego, CA5MShares$32.5 Million2.76% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.2MShares$27.3 Million1.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$26.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$21.6 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.47MShares$16.1 Million1.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $365M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...